Greg Cosentino

Greg Cosentino, PhD, has extensive experience in biopharmaceutical manufacturing and technology transfer, currently holding the title of Retired Director at the Centre de production de produits biologiques. Prior roles include serving as a Manufacturing Sciences & Technology Transfer Specialist at the National Research Council Canada, where responsibilities involved the technology transfer and life cycle management of biopharmaceutical products in a GMP-compliant environment, particularly during the COVID-19 crisis. Previous positions include Associate Director at Jubilant DraxImage, Director of Technology Transfer at ProMetic Life Sciences Inc., and various leadership roles at Jubilant HollisterStier, Therapure Biopharma Inc., PerkinElmer, and DSM Biologics, alongside significant contributions to research and development in biochemistry. Greg Cosentino holds a PhD in Biochemistry from McGill University and master’s and bachelor’s degrees in Biochemical Engineering and Biochemistry, respectively, from Western University.